Viral vectors are commonly used in clinical trials to evaluate gene therapies. Due to instability, these vectors are difficult to produce and analyze. Current assays lack the sensitivity required and might be affected by the sample matrix. Fredrik Sundberg at Cytiva shares our recent SPR assay developments for measuring adenovirus and adeno-associated virus titers.
WATCH NOW >>
June 2, 2022